156 related articles for article (PubMed ID: 16490928)
1. A novel receptor on allograft (H-2d)-induced macrophage (H-2b) toward an allogeneic major histocompatibility complex class I molecule, H-2Dd, in mice.
Tashiro-Yamaji J; Einaga-Naito K; Kubota T; Yoshida R
Microbiol Immunol; 2006; 50(2):105-16. PubMed ID: 16490928
[TBL] [Abstract][Full Text] [Related]
2. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
Tashiro-Yamaji J; Kubota T; Yoshida R
Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
[TBL] [Abstract][Full Text] [Related]
3. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts.
Yoshida R; Oku T; Takikawa O; Einaga-Naito K; Yoneda Y; Hirota R; Kubota T
Microbiol Immunol; 2000; 44(1):57-67. PubMed ID: 10711600
[TBL] [Abstract][Full Text] [Related]
5. MHC class I recognition by monocyte-/macrophage-specific receptors.
Yoshida R
Adv Immunol; 2014; 124():207-47. PubMed ID: 25175777
[TBL] [Abstract][Full Text] [Related]
6. Infiltration of H-2d-specific cytotoxic macrophage with unique morphology into rejection site of allografted meth A (H-2d) tumor cells in C57BL/6 (H-2b) mice.
Nomi H; Tashiro-Yamaji J; Miura-Takeda S; Shimizu T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
Microbiol Immunol; 2007; 51(3):297-306. PubMed ID: 17380049
[TBL] [Abstract][Full Text] [Related]
7. Specific binding of HLA-B44 to human macrophage MHC receptor 1 on monocytes.
Tashiro-Yamaji J; Shimizu T; Hayashi M; Yamana H; Tanigawa N; Uchiyama K; Kubota T; Yoshida R
Gene; 2012 Jun; 501(2):127-34. PubMed ID: 22525042
[TBL] [Abstract][Full Text] [Related]
8. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
[TBL] [Abstract][Full Text] [Related]
9. A third class I major histocompatibility complex antigen encoded by a gene in the D region of the H-2d haplotype recognized by cytotoxic T lymphocytes.
Mann DW; Forman J
Immunogenetics; 1988; 28(1):38-45. PubMed ID: 3259946
[TBL] [Abstract][Full Text] [Related]
10. HLA-B62 as a possible ligand for the human homologue of mouse macrophage MHC receptor 2 (MMR2) on monocytes.
Shimizu T; Tashiro-Yamaji J; Hayashi M; Inoue Y; Ibata M; Kubota T; Tanigawa N; Yoshida R
Gene; 2010 Apr; 454(1-2):31-8. PubMed ID: 20123006
[TBL] [Abstract][Full Text] [Related]
11. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells.
Yamamoto N; Einaga-Naito K; Kuriyama M; Kawada Y; Yoshida R
Transplantation; 1998 Mar; 65(6):818-25. PubMed ID: 9539094
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
Drizlikh G; Schmidt-Sole J; Yankelevich B
J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
14. The NK cell MHC class I receptor Ly49A detects mutations on H-2Dd inside and outside of the peptide binding groove.
Matsumoto N; Yokoyama WM; Kojima S; Yamamoto K
J Immunol; 2001 Apr; 166(7):4422-8. PubMed ID: 11254697
[TBL] [Abstract][Full Text] [Related]
15. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection.
Grigoriadou K; Ménard C; Pérarnau B; Lemonnier FA
Eur J Immunol; 1999 Nov; 29(11):3683-90. PubMed ID: 10556824
[TBL] [Abstract][Full Text] [Related]
16. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
17. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage.
Ushio-Umeda Y; Yoshida R
Microbiol Immunol; 1997; 41(12):981-90. PubMed ID: 9492184
[TBL] [Abstract][Full Text] [Related]
19. Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity.
Polakova K; Plaksin D; Chung DH; Belyakov IM; Berzofsky JA; Margulies DH
J Immunol; 2000 Nov; 165(10):5703-12. PubMed ID: 11067928
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells.
Yu YY; Forman J; Aldrich C; Blazar B; Flaherty L; Kumar V; Bennett M
Int Immunol; 1994 Sep; 6(9):1297-306. PubMed ID: 7529556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
